In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with [125I]MRK-16 monoclonal antibody
- 31 May 1995
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 22 (4) , 497-504
- https://doi.org/10.1016/0969-8051(94)00127-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P‐glycoproteinInternational Journal of Cancer, 1993
- Reversal of Drug Resistance in a Human Colon Cancer Xenograft Expressing MDR1 Complementary DNA by In Vivo Administration of MRK-16 Monoclonal AntibodyJNCI Journal of the National Cancer Institute, 1991
- Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast CarcinomaJNCI Journal of the National Cancer Institute, 1991
- Inhibition of Multidrug-resistant Human Tumor Growth in Athymic Mice by Anti-P-glycoprotein Monoclonal AntibodiesJapanese Journal of Cancer Research, 1989
- Quantitative SPECT in radiation dosimetrySeminars in Nuclear Medicine, 1989
- Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoproteinBiochemical Pharmacology, 1988
- MECHANISMS OF MULTIDRUG RESISTANCE AND IMPLICATIONS FOR THERAPYJapanese Journal of Cancer Research, 1988
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: Role of protein bindingCancer Letters, 1987
- Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.Journal of Clinical Investigation, 1986